Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yong Zhou
OpenAlex ID:
A5158685204
Neoadjuvant Pertuzumab Biosimilar HLX11 versus Reference Pertuzumab for Early-Stage or Locally Advanced Breast Cancer: A Phase III Equivalence Trial
2026
·
Jin Zhang
, Jinhai Zhu
, et al.
·
Clinical Cancer Research
Show more works
View as search
Works count:
1
Citation count:
H-index:
I10-index:
Year
Topic
Type
